Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease
生物工程皮质微组织模型来研究阿尔茨海默病中的人类小胶质细胞
基本信息
- 批准号:10630949
- 负责人:
- 金额:$ 18.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAPP-PS1AcuteAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease therapeuticAmyloidosisAnimalsAwardBehaviorBiological AssayBiological ModelsBiologyBiomedical EngineeringBrainCharacteristicsChimera organismCommunitiesCuesCustomData SetDevelopmentDiseaseDissociationElementsEngineeringEngraftmentFutureGene ExpressionGenerationsGeneticGenetic TranscriptionGenotypeGoalsGrowthHealthHumanHybridsImageIn VitroInflammatoryInterventionKnowledgeLabelLightLinkLipopolysaccharidesMechanicsMeta-AnalysisMethodologyMethodsMicrogliaMissionModelingMoldsMonitorMorphologyMusMutationNeonatalNerve DegenerationNeurodegenerative DisordersNeuronsOrganoidsOutcomePathogenesisPathogenicityPathologicPathologyPatientsPhenotypePhysiologicalPrevention strategyPropertyPublic HealthPublishingRat StrainsRat TransgeneRattusResearchRestScienceSortingSupport SystemSystemTechniquesTestingTherapeuticTissue ModelTissuesTransgenic OrganismsTransplantationUnited States National Institutes of HealthV717Fbrain cellcell typecost effectivedesigndisabilityfallsfightingglial activationimprovedin vivoinduced pluripotent stem cellinnovationmutantneuralneuroinflammationoperationprogramsreconstitutionresponsescaffoldstem cellstau Proteinsthree dimensional cell culturetooltranscriptomicstranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
Microglia are highly sensitive to the extrinsic cues from their microenvironment in a context-specific manner and
rapidly change around diverse cellular states via intrinsic transcriptional programs. The specific microglial state
that contributes to Alzheimer’s Disease (AD) pathology is still illy defined, mostly owing to the longstanding critical
need for a reliable and robust modeling tool. In light of the substantial difference between human and mouse
microglia, the iPSC-derived human microglia (iMG) have emerged as a rigorous platform to investigate
neuroinflammation and AD-linked genetics. A recent transition from 2D to 3D culture systems further enhances
the utility of iMG in understanding AD pathogenesis, but technical barriers remain. An improvement to achieve
better cellular diversity and functionality in a scalable 3D neural setting will make a desired tool that enables
precise monitoring and manipulations of iMG inside a stringently controlled brain-like milieu. Our long-term goal
is to understand the pathogenic determinants of neuroinflammation to inform crucial future treatment for AD, via
stem cell and engineering innovations. To this end, we propose here to introduce an original 3D culture platform
to examine the extrinsic and intrinsic elements of microglial activation in health and in AD, based on patient-
derived iMG grown in engineered primary rat cortical microtissues. Leveraging validated AD mutant iPSCs and
transgenic AD rats, our overall objectives are to 1) confirm the capability of our hybrid model to recapitulate
human-specific, AD-related microglia features and signature and 2) to characterize the ‘ground state’ and
neuroinflammatory responses of control and AD iMG under a physiological or pathological microenvironment
(i.e. wildtype vs. AD transgenic microtissue). Supported by our preliminary studies, our central hypothesis is that
the iMG-microtissue growth system supports maturation and operation of human microglia and can be utilized
to detect the nuances in microglial behaviors that may contribute to AD pathogenesis. Our specific aims are to
test our working hypotheses that 1) iMG populated in cortical microtissues mimic homeostatic human microglia
in vivo and can be phenotyped for microglia-intrinsic manifestations contributed by genotypes, and that 2) iMG
maintained in AD mutant microtissues are affected by the AD-promoting extrinsic cues and show disease-
associated characteristics. Our expected outcomes are to 1) establish a new-generation in vitro human microglia
model system that uniquely allows dissecting the intertwined influences from AD-linked genetics and
microenvironment on microglial functions and 2) to acquire a distinctive dataset that would offer a framework to
pinpoint critical microglia characteristics for AD. We believe an expansion of this research beyond this award
period to characterize in depth the microglial findings uncovered here will ultimately bring a valuable opportunity
for the development of much-needed intervention and prevention strategies for AD.
项目总结/摘要
小胶质细胞对来自其微环境的外部线索高度敏感,
通过内在转录程序在不同的细胞状态周围迅速变化。特定的小胶质细胞状态
导致阿尔茨海默病(AD)病理学的因素仍然没有明确的定义,主要是由于长期以来的关键因素,
需要一个可靠和强大的建模工具。鉴于人类和老鼠之间的实质性差异
小胶质细胞,iPSC衍生的人类小胶质细胞(iMG)已经成为研究小胶质细胞的严格平台。
神经炎症和AD连锁遗传学。最近从2D到3D培养系统的转变进一步增强了
iMG在了解AD发病机制中的效用,但技术障碍仍然存在。一个改进,以实现
在可扩展的3D神经环境中更好的细胞多样性和功能性将成为一种期望的工具,
在严格控制的类脑环境中精确监测和操纵iMG。我们的长期目标
是了解神经炎症的致病决定因素,为AD的未来治疗提供重要信息,
干细胞和工程创新。为此,我们建议在这里引入一个原创的3D文化平台,
根据患者的情况,检查健康和AD中小胶质细胞激活的外在和内在因素,
衍生的iMG在工程化的原代大鼠皮质微组织中生长。利用经验证的AD突变iPSC和
转基因AD大鼠,我们的总体目标是1)确认我们的杂交模型的能力,
人类特异性的AD相关小胶质细胞特征和标记,以及2)表征“基态”,
在生理或病理微环境下对照和AD iMG的神经炎症反应
(i.e.野生型对AD转基因微组织)。根据我们的初步研究,我们的中心假设是,
iMG-微组织生长系统支持人小胶质细胞的成熟和操作
以检测可能导致AD发病机制的小胶质细胞行为的细微差别。我们的具体目标是
测试我们的工作假设:1)iMG在皮质微组织中的分布模拟了稳态的人类小胶质细胞
在体内,并且可以针对由基因型贡献的小胶质细胞内在表现进行表型分型,以及2)iMG
维持在AD突变体微组织中的细胞受到促进AD的外部线索的影响,并显示疾病-
相关特征。我们的预期结果是:1)建立新一代的体外人类小胶质细胞
模型系统,独特地允许解剖AD连锁遗传学的交织影响,
2)获得一个独特的数据集,这将提供一个框架,
找出AD的关键小胶质细胞特征我们相信这项研究的扩展超出了这个奖项
深入描述此处发现的小胶质细胞研究结果的一段时间将最终带来宝贵的机会
制定急需的AD干预和预防策略。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Three-Dimensional Primary Cortical Culture System Compatible with Transgenic Disease Models, Virally Mediated Fluorescence, and Live Microscopy.
与转基因疾病模型、病毒介导的荧光和活体显微镜兼容的三维原代皮质培养系统。
- DOI:10.1007/978-1-0716-3287-1_12
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Brown,Sophie;Atherton,Elaina;Borton,DavidA
- 通讯作者:Borton,DavidA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Allenson Borton其他文献
David Allenson Borton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Allenson Borton', 18)}}的其他基金
Bridging bench to bedside with aneurotechnology cross-development platform
通过神经技术交叉开发平台将工作台与床边桥接起来
- 批准号:
10640424 - 财政年份:2023
- 资助金额:
$ 18.64万 - 项目类别:
Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease
生物工程皮质微组织模型来研究阿尔茨海默病中的人类小胶质细胞
- 批准号:
10448954 - 财政年份:2022
- 资助金额:
$ 18.64万 - 项目类别:
Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum
沿着脊柱-大脑连续体的疼痛回路的时空编码
- 批准号:
10205394 - 财政年份:2021
- 资助金额:
$ 18.64万 - 项目类别:
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
加速临床研究植入式神经技术的传播
- 批准号:
10470025 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
加速临床研究植入式神经技术的传播
- 批准号:
10689290 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
加速临床研究植入式神经技术的传播
- 批准号:
10238761 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Large Scale Cortical Laminar Recordings: Novel Instrumentation
大规模皮质层流记录:新颖的仪器
- 批准号:
10078368 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum
沿着脊柱-大脑连续体的疼痛回路的时空编码
- 批准号:
10305343 - 财政年份:2018
- 资助金额:
$ 18.64万 - 项目类别:
The Role of M1 Leg Area in Volitional and Stereotyped Control of the Lower Limb
M1 腿部区域在下肢意志和刻板控制中的作用
- 批准号:
10021472 - 财政年份:2018
- 资助金额:
$ 18.64万 - 项目类别:
Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum
沿着脊柱-大脑连续体的疼痛回路的时空编码
- 批准号:
10267899 - 财政年份:2018
- 资助金额:
$ 18.64万 - 项目类别:
相似海外基金
Selective over expression of TDP-43 in APP/PS1 mice alters APP processing
APP/PS1 小鼠中 TDP-43 的选择性过度表达改变了 APP 加工
- 批准号:
8699634 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
Selective over expression of TDP-43 in APP/PS1 mice alters APP processing
APP/PS1 小鼠中 TDP-43 的选择性过度表达改变了 APP 加工
- 批准号:
8581908 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
Selective over expression of TDP-43 in APP/PS1 mice alters APP processing
APP/PS1 小鼠中 TDP-43 的选择性过度表达改变了 APP 加工
- 批准号:
8878968 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
Selective over expression of TDP-43 in APP/PS1 mice alters APP processing
APP/PS1 小鼠中 TDP-43 的选择性过度表达改变了 APP 加工
- 批准号:
8795347 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
The role of ABCA1 in mediating the beneficial effects of GW3965 on biochemical and cognitive outcomes in the APP/PS1 mouse model of Alzheimer's Disease
ABCA1 在介导 GW3965 对阿尔茨海默病 APP/PS1 小鼠模型生化和认知结果的有益影响中的作用
- 批准号:
179339 - 财政年份:2009
- 资助金额:
$ 18.64万 - 项目类别:
Fellowship Programs
Early diagnosis of alzheimer's disease in app/ps1 transgenic mice
app/ps1 转基因小鼠阿尔茨海默病的早期诊断
- 批准号:
347789-2008 - 财政年份:2008
- 资助金额:
$ 18.64万 - 项目类别:
Postgraduate Scholarships - Master's
Early diagnosis of alzheimer's disease in app/ps1 transgenic mice
app/ps1 转基因小鼠阿尔茨海默病的早期诊断
- 批准号:
347789-2007 - 财政年份:2007
- 资助金额:
$ 18.64万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's